LMR Partners’s Whitehawk Therapeutics WHWK Stock Holding History

LMR Partners’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18,582	Closed	-$315K	–	1503
2022 Q1	$315K	Buy	+18,582	New	+$356K	﹤0.01%	1066

Other funds holding WHWK

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

LMR Partners's WHWK Position: Q2 2022 in Review

LMR Partners sold out of Whitehawk Therapeutics (WHWK) in Q2 2022, closing a stake of 18,582 shares — an estimated $315K sold.

LMR Partners first reported a position in WHWK in Q1 2022 and held it in 1 quarter. The position peaked at $315K in Q1 2022. 68 funds tracked by Wall St. Rank hold WHWK as of Q2 2022.

LMR Partners reported no remaining Whitehawk Therapeutics position as of Q2 2022 after selling out during the quarter.
LMR Partners sold 18,582 Whitehawk Therapeutics shares in Q2 2022, an estimated $315K.
LMR Partners first reported a position in Whitehawk Therapeutics in Q1 2022 and held it in 1 quarter.
LMR Partners's Whitehawk Therapeutics position peaked at $315K in Q1 2022.
68 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2022.

Based on LMR Partners's 13F filing for Q2 2022, filed 15 Aug 2022.